Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: OSUR

OraSure Technologies, Inc.

Healthcare | Medical - Instruments & Supplies

No licensed closing price on file for OSUR. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-0.70

OraSure Technologies, Inc. (NASDAQ: OSUR) is a medical instruments and supplies company. Figures from SEC EDGAR; updated 2026-10-21 08:28 UTC.

What OraSure Technologies, Inc. does

OTI is a company that develops, manufactures, and distributes rapid point-of-care diagnostic tests and sample management solutions. The company's diagnostic products test for infectious diseases including HIV, Hepatitis C virus, Syphilis, Sickle Cell, and COVID-19, and are sold to clinical laboratories, hospitals, clinics, public health organizations, and government agencies in the United States and internationally. The company also offers consumer-friendly formats of certain tests, including over-the-counter HIV and COVID-19 products in the U.S.

Summarized from OraSure Technologies, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-0.70

Revenue, margins & earnings

FY2021: net loss $23M on revenue $234M$234MFY2021FY2022: net loss $17M on revenue $387M$387MFY2022FY2023 Revenue: $405M — margin split not shown (non-operating gains)$405MFY2023FY2024: net loss $20M on revenue $186M$186MFY2024FY2025: net loss $69M on revenue $115M$115MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-01
  • 2026-10-01DirectorAward4,797$18.6K
  • 2026-09-09DirectorTax withholding-5,116$17.5K
  • 2026-06-30DirectorAward3,666$16.2K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does OraSure Technologies, Inc. do?

OTI is a company that develops, manufactures, and distributes rapid point-of-care diagnostic tests and sample management solutions.

When did OSUR last file with the SEC?

OraSure Technologies, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-11. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-21 08:28 UTC. This page is also available as JSON at /api/data?ticker=OSUR and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for OSUR and 5,000+ tickers.

Create a free account — keep OSUR
For your agent
GET /api/data?ticker=OSUR

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt